Genprex, Inc. (GNPX:NASDAQ) Investor Relations Material

Overview

Austin-based Genprex, Inc., a clinical-stage gene therapy company specializing in cancer and diabetes treatments, is making strides with its lead product candidate REQORSA (GPX-001). REQORSA has shown great promise in treating non-small cell lung cancer and small cell lung cancer. In addition, the company is in the process of developing GPX-002, a gene therapy still in a preclinical stage, as a potential treatment for diabetes. Founded in 2009, Genprex, Inc. has continued to prioritize innovation and cutting-edge research in its mission to improve treatment outcomes for cancer and diabetes patients.

Annual Reports

Frequently Asked Questions

What is Genprex, Inc.'s ticker?

Genprex, Inc.'s ticker is GNPX

What exchange is Genprex, Inc. traded on?

The company's shares trade on the NASDAQ stock exchange

Where are Genprex, Inc.'s headquarters?

They are based in Austin, Texas

How many employees does Genprex, Inc. have?

There are 1-10 employees working at Genprex, Inc.

What is Genprex, Inc.'s website?

It is https://www.genprex.com/

What type of sector is Genprex, Inc.?

Genprex, Inc. is in the Healthcare sector

What type of industry is Genprex, Inc.?

Genprex, Inc. is in the Biotechnology industry

Who are Genprex, Inc.'s peers and competitors?

The following five companies are Genprex, Inc.'s industry peers:

- Therapix Biosciences Ltd.

- Novus Therapeutics, Inc.

- Heat Biologics, Inc.

- 9 Meters Biopharma, Inc.

- Vascular Biogenics Ltd.